IPID LEVELS IN KIDNEY DISEASE.
Not Applicable
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2019/01/017132
- Lead Sponsor
- Vishwanath Matur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with chronic kidney disease with established chronic kidney disease irrespective of the etiology.
2.Above the age of 18 years.
3.On conservative treatment and pre dialysis patients and patients who underwent dialysis treatment for chronic kidney disease.
4.As evidenced radiologically or biochemically (elevated blood urea, serum creatinine) for more than 3 months
Exclusion Criteria
1.PREGNANT WOMEN
2.AKI PATIENTS
4.PATIENTS WHO ARE ON LIPID ALTERING AGENTS LIKE B-BLOCKERS,OCPS,THIAZIDES.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method total cholesterol, HDL-Cholesterol, LDL-Cholesterol and triglyceride levelsTimepoint: 1 WEEK
- Secondary Outcome Measures
Name Time Method The spectrum of lipid disorders in chronic kidney disease (CKD) is usually characterized by high triglycerides and reduced high dense lipoprotein (HDL), associated with normal or slightly incread low dense lipoprotein (LDL)-cholesterol.Timepoint: EVERY 6 MONTHS